Table 1.

Clinicopathologic data of EGFR mutant resected lung adenocarcinomas studied

Case no.AgeGenderRaceSmoking statusStageEGFR mutationMutation in normal epithelium
155FemaleCaucasianNeverIIB15 bp del (746-750)Yes
270FemaleHispanicNeverIIIA15 bp del (746-750)No
364MaleCaucasianNeverIA15 bp del (746-750)No
466FemaleCaucasianNeverIB18 bp del (746-751) and S752VNo
552FemaleHispanicNeverIIIAL858RYes
670FemaleCaucasianNeverIAL858RYes
765FemaleCaucasianNeverIAL858RNo
845FemaleEast AsianNeverIAL858RNo
961FemaleEast AsianNeverIIIAL858RNo
1049FemaleEast AsianNeverIIIAL858RNo
1135FemaleEast AsianNeverIA15 bp del (746-750)Yes
1262FemaleEast AsianNeverIAL858RNo
1366FemaleCaucasianFormerIV15 bp del (746-750)No
1458FemaleCaucasianFormerIA15 bp del (746-750)Yes
1565MaleEast AsianFormerIIB18 bp del (746-751) and S752IYes
1672FemaleCaucasianFormerIB15 bp del (746-750)Yes
1769MaleEast AsianFormerIIIAL858RNo
1856MaleEast AsianFormerIIB18 bp del (747-752) and P753QYes
1969MaleEast AsianFormerIB15 bp del (747-751)No
2073MaleEast AsianCurrentIIB15 bp del (746-750)Yes
2168FemaleCaucasianCurrentIIIA15 bp del (746-750)No